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IN AORTIC STENOSIS, 2D SPECKLE TRACKING 
DIFFERENTIATES LEFT VENTRICULAR DYSFUNCTION 
LOAD- TO REMODELLING-DEPENDANT
V. COUTANT 1, M. BERNARD 1, A. ZAJARIAS 1, M. LEMERCIER 1, 
M. CHALLE 1, S. GUENDOUZ 1, C. TRON 1, H. ELTCHANINOFF 1, 
A. CRIBIER 1, F. BAUER 1
1 Service de cardiologie, CHU Charles Nicolle, Rouen, France
Background — In aortic stenosis, it is not known which between 
longitudinal, radial and circumferential contraction is in uenced 
by loading conditions or remodelling. To test our hypothesis and 
to understand left ventricular function recovery, we investigated 
patients at early, i.e. 7 days (contractility enhancement load-
dependant) and at late follow-up, i.e. 3 months (contractility 
enhancement remodelling-dependant) after transcutaneous aortic 
valve implantation (TAVI).
Methods and Results — Twenty-three subjects (AS: valve 
ori ce < or =0.7 cm²; 14 female ; mean age, 84+/-6 years) were 
studied. All subjects of the study had conventional 2D-Doppler 
echocardiography and speckle tracking analysis (GE HealthCare). 
Speckle tracking was sampled in short-axis view for radial and 
circumferential strain and in apical 4, 3 and 2-chamber view for 
averaged longitudinal strain. Measurements were performed 
before, 7 days and 3 months after TAVI. Mean pressure gradient 
decreased from 41±20 mm Hg to 10±3 mm Hg (p<0.001) while aortic 
valve area increased from 0.6±0.1 to 1.7±0.2 cm² (p<0.001) after 
implantation. Biplane Simpson EF was 50±10 %, 51±13 and 58±11 % 
at baseline, 7-day and 3-month follow-up (p=0.01), respectively. 
Improvement of circumferential strain found 7 days after TAVI is 
sustained at 3 months. Radial strain increased shortly after TAVI, 
then decreased at 3 months and was compensated by improvement 
of longitudinal strain (see  gure).
Conclusion — In patients with aortic stenosis, radial contraction 
is load dependant, circumferential contraction is both load- and 
remodelling-dependant, whereas longitudinal contraction is 
remodeling-dependant.
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GENERATION OF A TRANSGENIC MODEL 
OF INDUCIBLE CARDIOMYOCYTE DEATH BY 
IMMUNO-MEDIATED CELL TARGETING
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In the western world, heart failure, which develops for instance 
secondary to myocardial infarction, is a major cause of death. 
Usually, the heart adapts to a primary insult through cardiomyocyte 
hypertrophy. The emerging concept, however, is that cardiac stem 
cells contribute to cardiomyocyte renewal in the myocardium. The 
rate of replacement is low in the normal heart, and is thought 
to be higher during the response to injury. In this context, the 
present work aims at generating a transgenic model of inducible 
cardiomyocyte death to evaluate the degree of cardiac stem cell 
mobilization during the adaptation of the heart to stress. Therefore, 
we produced transgenic mice with cardiac-speci c overexpression of 
the human CD25 (hCD25) under control of the a-MHC promoter. This 
transmembrane protein is inactive in the mouse. However, LMB2, 
an immunotoxin derived from the Pseudomonas exotoxin directed 
against hCD25, can be administrated to speci cally target hCD25-
expressing cardiomyocytes and induce apoptosis. Cardiac-speci c 
expression of hCD25 in transgenics was demonstrated by RT-PCR, 
Western blot analysis and immunohistochemistry. Administration of 
LMB2 to neonatal transgenic cardiomyocytes in culture resulted in 
signi cant cell death. Surviving cardiomyocytes showed abnormal, 
star-shaped morphology and disorganized sarcomeric structure. In 
vivo, administration of LMB2 to neonatal transgenics resulted in 
increased apoptosis after LMB2 injection and signi cant mortality. 
The number of dying mice increased proportionally to the dose of 
injected LMB2. Surviving transgenic mice sacri ced 3 days after 
LMB2 administration showed decreased cardiac weight, disorganized 
cardiac tissue and increased  brosis. In adult transgenic mice, 
LMB2 treatment resulted in impaired cardiac function, as shown by 
echocardiography analysis, and animal death at doses of 300 ng/g 
and above. Post-mortem analysis revealed necrotic and  brous 
cardiac tissues. This model is currently used to induce non-lethal 
apoptosis in adult animals in view to investigate cardiac precursor 
recruitment and potential regeneration in the damaged heart.
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